Boston Scientific Corp.’s plan to acquire Relievant Medsystems Inc. is part of its ongoing effort to address chronic pain which is significantly impacting the quality of life of millions of people. Relievant’s Intracept intraosseous nerve ablation system will give Boston Scientific another tool in its armory to tackle chronic pain which already includes radiofrequency ablation (RFA) solutions and spinal cord stimulator (SCS) systems.
By Colin Kellaher Boston Scientific has agreed to acquire smaller medical-technology company Relievant Medsystems for an initial $850 million in cash in a.
By Colin Kellaher Boston Scientific has agreed to acquire smaller medical-technology company Relievant Medsystems for an initial $850 million in cash in a deal that expands its portfolio of.
Boston Scientific to buy Relievant Medsystems for at least $850M startribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from startribune.com Daily Mail and Mail on Sunday newspapers.